Entering or expanding within the United States cosmetic market requires more than innovative formulations and attractive packaging. Every cosmetic product sold in the US must align with a complex legal framework designed to protect consumer safety and ensure market transparency. US Cosmetic Law establishes the legal backbone governing how cosmetics are manufactured, labeled, distributed, and monitored.
Recent legislative changes have significantly strengthened regulatory oversight, placing greater responsibility on cosmetic companies to demonstrate compliance. Understanding these legal expectations—and implementing them correctly—has become a critical business necessity rather than an optional administrative task.
XPRO America operates as a professional US FDA Consultancy, supporting cosmetic manufacturers, brand owners, private labelers, and importers with end-to-end regulatory compliance solutions under US Cosmetic Law.
The Legal Basis of US Cosmetic Law
US Cosmetic Law originates primarily from the Federal Food, Drug, and Cosmetic Act (FD&C Act). This law grants the US Food and Drug Administration authority to regulate cosmetics to prevent adulteration, misbranding, and unsafe products from entering the marketplace.
Historically, cosmetic regulation in the US relied heavily on manufacturer self-responsibility. However, with the passage of the Modernization of Cosmetics Regulation Act (MoCRA), the regulatory environment has shifted toward mandatory oversight and enhanced enforcement.
Together, these laws define:
- What qualifies as a cosmetic
- How cosmetics must be produced
- How they must be labeled
- What documentation companies must maintain
- How FDA can enforce compliance
What Products Fall Under US Cosmetic Law
A cosmetic is any product intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance.
Examples include:
- Skin creams and lotions
- Makeup products
- Shampoos and conditioners
- Perfumes and fragrances
- Deodorants
- Nail care products
If a product claims to treat or prevent disease, or affect the structure or function of the body, it may be classified as a drug rather than a cosmetic, triggering an entirely different regulatory pathway.
Correct product classification is one of the most important first steps in compliance.
Facility Registration Obligations
Under MoCRA, cosmetic manufacturing and processing facilities must register with the FDA. This requirement applies to:
- US-based facilities
- Foreign facilities shipping cosmetics to the US
Registration involves submitting facility identification details, business operations, and contact information. Facilities must renew their registration every two years and update records when changes occur.
Foreign manufacturers must also appoint a US Agent who acts as the FDA’s domestic point of contact.
XPRO America manages facility registration and US Agent designation to ensure uninterrupted regulatory standing.
Cosmetic Product Listing Requirements
In addition to facility registration, each cosmetic product marketed in the United States must be listed with the FDA.
Product listing includes:
- Product name
- Cosmetic category
- Ingredient composition
- Associated facility information
- Responsible person details
Listings must be updated annually and whenever formulations or product details change.
Accurate product listing strengthens regulatory transparency and reduces import delays.
Ingredient Compliance Under US Cosmetic Law
US Cosmetic Law prohibits or restricts certain substances in cosmetic formulations. While most cosmetic ingredients do not require premarket approval, companies are responsible for ensuring their ingredients are safe and legally permitted.
Key areas of concern:
- Prohibited substances
- Restricted-use ingredients
- Color additive authorization
- Contaminant limits (e.g., heavy metals)
Ingredient compliance failures can result in product detention or recall.
XPRO America performs ingredient assessments to identify regulatory risks before products enter the market.
Safety Substantiation: A Core Legal Requirement
MoCRA introduced a mandatory requirement for cosmetic companies to maintain adequate safety substantiation for every product.
Safety substantiation demonstrates, through scientifically valid evidence, that a cosmetic product is safe for its intended use.
Acceptable evidence may include:
- Toxicological evaluations
- Ingredient safety assessments
- Product testing data
- Scientific literature reviews
These records must be readily accessible during FDA inspections.
XPRO America prepares safety documentation packages aligned with FDA expectations.
Good Manufacturing Practices (GMP)
US Cosmetic Law requires cosmetics to be produced under sanitary and controlled conditions to prevent contamination and quality defects.
Core GMP elements include:
- Clean and well-maintained facilities
- Controlled manufacturing processes
- Validated cleaning procedures
- Raw material qualification
- Finished product testing
- Staff training
- Documented quality systems
FDA inspectors may evaluate GMP compliance during facility inspections.
XPRO America provides GMP consulting services to help companies establish compliant manufacturing systems.
Labeling Compliance Under US Cosmetic Law
Cosmetic labeling is one of the most common areas of FDA enforcement.
Labels must be truthful, not misleading, and contain mandatory information:
- Product identity
- Net quantity of contents
- Ingredient declaration using INCI names
- Name and address of responsible company
- Required warnings, if applicable
Claims must stay within cosmetic boundaries. Drug-type claims can trigger reclassification and regulatory action.
XPRO America reviews and corrects cosmetic labels to ensure full legal compliance.
Adverse Event Reporting Responsibilities
Companies must report serious adverse events associated with cosmetic products to the FDA within 15 business days.
Serious adverse events include:
- Hospitalization
- Life-threatening reactions
- Permanent impairment
- Birth defects
- Death
All adverse event records must be retained for six years.
XPRO America establishes reporting and recordkeeping systems for cosmetic brands.
Import Compliance for Foreign Manufacturers
Foreign cosmetic companies must meet the same legal standards as US manufacturers.
Critical import compliance elements include:
- Registered manufacturing facility
- Listed products
- Compliant labeling
- Ingredient conformity
- Accurate customs documentation
Non-compliant shipments may be refused entry or placed on import alert.
XPRO America supports importers and exporters through the entire compliance process.
US FDA Enforcement Powers Under US Cosmetic Law
The FDA has authority to:
- Issue warning letters
- Mandate product recalls
- Seize non-compliant products
- Place companies on import alert
- Seek court injunctions
Proactive compliance is the best protection against enforcement actions.
Strategic Value of Compliance
Beyond legal protection, strong compliance programs provide:
- Increased retailer acceptance
- Improved consumer confidence
- Faster market access
- Stronger brand credibility
- Reduced business risk
Compliance becomes a competitive advantage.
How XPRO America Supports Cosmetic Compliance
XPRO America functions as a specialized US FDA Consultancy delivering comprehensive cosmetic regulatory services:
- Facility Registration
- Product Listing
- US Agent Services
- Ingredient Review
- Safety Substantiation
- GMP Consulting
- Labeling Review
- Adverse Event Reporting Systems
- Import Compliance Support
To connect with XPRO America’s regulatory specialists, brands can write to support@xproamerica.com for professional guidance.
Conclusion
US Cosmetic Law has evolved into a robust regulatory framework that demands accountability, transparency, and scientific validation from cosmetic companies. Brands that invest in compliance early avoid costly delays, enforcement actions, and reputational harm.
With expert guidance from XPRO America, cosmetic businesses can confidently navigate US Cosmetic Law, achieve regulatory compliance, and focus on building successful brands in the United States market.
Leave a Reply